| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.771 | 0.003 | 0.771 | Rho-associated kinase II inhibitor | 0.507 0.004 DBMET00728 0.576 0.004 DBMET00736 | ||
| 0.689 | 0.004 | 0.689 | Rho-associated kinase inhibitor | 0.324 0.005 DBMET00728 0.397 0.005 DBMET00736 | ||
| 0.608 | 0.004 | 0.608 | Aurora-A kinase inhibitor | 0.203 0.025 DBMET00728 0.23 0.02 DBMET00736 | ||
| 0.57 | 0.003 | 0.57 | Tyrosine-protein kinase EMT inhibitor | 0.059 0.039 DBMET00736 | ||
| 0.515 | 0.003 | 0.571 | Alcohol dehydrogenase inhibitor | 0.571 0.003 DBMET00728 0.387 0.004 DBMET00736 | DBMET00728 | |
| 0.512 | 0.023 | 0.512 | GABA C receptor rho-3 antagonist | 0.45 0.041 DBMET00728 0.386 0.068 DBMET00736 | ||
| 0.516 | 0.031 | 0.65 | Aldehyde oxidase inhibitor | 0.65 0.013 DBMET00728 0.467 0.037 DBMET00736 | DBMET00728 | |
| 0.483 | 0.038 | 0.611 | 5 Hydroxytryptamine release inhibitor | 0.611 0.009 DBMET00728 0.408 0.073 DBMET00736 | DBMET00728 | |
| 0.498 | 0.054 | 0.498 | MAP kinase 1 inhibitor | 0.289 0.192 DBMET00728 0.288 0.193 DBMET00736 | ||
| 0.446 | 0.007 | 0.446 | Glycogen synthase kinase-3 inhibitor | 0.154 0.044 DBMET00728 0.261 0.02 DBMET00736 | ||
| 0.483 | 0.044 | 0.483 | 15-Lipoxygenase inhibitor | 0.357 0.095 DBMET00728 0.301 0.132 DBMET00736 | ||
| 0.438 | 0.004 | 0.438 | NMDA 2B receptor antagonist | 0.123 0.011 DBMET00728 0.348 0.004 DBMET00736 | ||
| 0.425 | 0.011 | 0.425 | CDC-like kinase 2 inhibitor | 0.301 0.031 DBMET00728 0.268 0.04 DBMET00736 | ||
| 0.421 | 0.01 | 0.421 | Cyclin-dependent kinase inhibitor | 0.137 0.063 DBMET00728 0.199 0.038 DBMET00736 | ||
| 0.425 | 0.017 | 0.46 | Peroxidase inhibitor | 0.46 0.013 DBMET00728 0.403 0.02 DBMET00736 | DBMET00728 | |
| 0.461 | 0.054 | 0.461 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.456 0.058 DBMET00728 0.328 0.177 DBMET00736 | ||
| 0.403 | 0.028 | 0.403 | Tyrosine kinase inhibitor | 0.284 0.046 DBMET00736 | ||
| 0.391 | 0.019 | 0.416 | Sodium/bile acid cotransporter inhibitor | 0.416 0.013 DBMET00728 0.371 0.028 DBMET00736 | DBMET00728 | |
| 0.373 | 0.006 | 0.373 | M18 aspartyl aminopeptidase inhibitor | 0.331 0.009 DBMET00728 0.251 0.02 DBMET00736 | ||
| 0.373 | 0.021 | 0.373 | Death-associated protein kinase 3 inhibitor | 0.302 0.037 DBMET00728 0.235 0.058 DBMET00736 | ||
| 0.37 | 0.019 | 0.37 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.267 0.045 DBMET00728 0.218 0.064 DBMET00736 | ||
| 0.351 | 0.007 | 0.351 | Histone acetyltransferase inhibitor | 0.258 0.023 DBMET00728 0.266 0.021 DBMET00736 | ||
| 0.349 | 0.005 | 0.349 | Protein kinase A inhibitor | 0.24 0.009 DBMET00728 0.236 0.01 DBMET00736 | ||
| 0.371 | 0.028 | 0.371 | Antimitotic | 0.211 0.078 DBMET00736 | ||
| 0.344 | 0.003 | 0.344 | CYP2A6 inhibitor | 0.125 0.025 DBMET00728 0.14 0.019 DBMET00736 | ||
| 0.344 | 0.007 | 0.344 | Ribosomal protein S6 kinase inhibitor | 0.176 0.049 DBMET00728 0.211 0.033 DBMET00736 | ||
| 0.359 | 0.025 | 0.359 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.208 0.061 DBMET00728 0.175 0.075 DBMET00736 | ||
| 0.353 | 0.027 | 0.353 | Clk dual-specificity kinase inhibitor | 0.2 0.079 DBMET00728 0.171 0.098 DBMET00736 | ||
| 0.327 | 0.005 | 0.327 | Activin receptor-like kinase 4 inhibitor | 0.143 0.032 DBMET00728 0.158 0.025 DBMET00736 | ||
| 0.328 | 0.017 | 0.328 | MAP-kinase-activated kinase 5 inhibitor | 0.278 0.042 DBMET00728 0.236 0.069 DBMET00736 | ||
| 0.313 | 0.006 | 0.313 | CDK2/cyclin A inhibitor | 0.14 0.03 DBMET00728 0.182 0.017 DBMET00736 | ||
| 0.32 | 0.021 | 0.32 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.247 0.037 DBMET00728 0.146 0.08 DBMET00736 | ||
| 0.307 | 0.012 | 0.307 | Cyclin-dependent kinase 2 inhibitor | 0.121 0.051 DBMET00728 0.167 0.032 DBMET00736 | ||
| 0.38 | 0.086 | 0.517 | Histamine release inhibitor | 0.517 0.023 DBMET00728 0.37 0.091 DBMET00736 | DBMET00728 | |
| 0.303 | 0.011 | 0.303 | Cyclin-dependent kinase 1 inhibitor | 0.137 0.046 DBMET00728 0.237 0.02 DBMET00736 | ||
| 0.317 | 0.028 | 0.317 | CDC-like kinase 4 inhibitor | 0.19 0.073 DBMET00728 0.157 0.096 DBMET00736 | ||
| 0.315 | 0.027 | 0.315 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.197 0.067 DBMET00728 0.256 0.046 DBMET00736 | ||
| 0.299 | 0.014 | 0.299 | Glycogen synthase kinase-3 beta inhibitor | 0.147 0.045 DBMET00728 0.165 0.037 DBMET00736 | ||
| 0.296 | 0.016 | 0.296 | Hemostatic | 0.262 0.02 DBMET00728 0.264 0.02 DBMET00736 | ||
| 0.304 | 0.024 | 0.304 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.214 0.129 DBMET00728 0.248 0.068 DBMET00736 | ||
| 0.408 | 0.134 | 0.817 | Antiinflammatory | 0.627 0.046 DBMET00728 0.817 0.013 DBMET00736 | DBMET00736 | |
| 0.273 | 0.005 | 0.273 | CDK2/cyclin E2 inhibitor | 0.145 0.018 DBMET00728 0.214 0.008 DBMET00736 | ||
| 0.293 | 0.042 | 0.293 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.152 0.142 DBMET00736 | ||
| 0.26 | 0.009 | 0.26 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.116 0.029 DBMET00728 0.184 0.015 DBMET00736 | ||
| 0.255 | 0.006 | 0.255 | Check point kinase 1 inhibitor | 0.118 0.021 DBMET00728 0.197 0.01 DBMET00736 | ||
| 0.321 | 0.072 | 0.321 | Calcium channel activator | 0.303 0.089 DBMET00728 0.287 0.105 DBMET00736 | ||
| 0.296 | 0.051 | 0.316 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.316 0.045 DBMET00728 0.251 0.067 DBMET00736 | DBMET00728 | |
| 0.261 | 0.018 | 0.261 | Heat shock protein 90 antagonist | 0.163 0.061 DBMET00728 0.151 0.074 DBMET00736 | ||
| 0.253 | 0.013 | 0.355 | Ferrochelatase inhibitor | 0.355 0.005 DBMET00728 0.149 0.038 DBMET00736 | DBMET00728 | |
| 0.26 | 0.026 | 0.285 | Nitric-oxide synthase stimulant | 0.22 0.06 DBMET00728 0.285 0.015 DBMET00736 | DBMET00736 | |
| 0.263 | 0.029 | 0.263 | RET inhibitor | 0.169 0.052 DBMET00736 | ||
| 0.254 | 0.022 | 0.574 | Alpha-N-acetylglucosaminidase inhibitor | 0.574 0.004 DBMET00728 0.44 0.007 DBMET00736 | DBMET00728 | |
| 0.287 | 0.057 | 0.295 | Dyrk kinase inhibitor | 0.295 0.054 DBMET00728 0.238 0.077 DBMET00736 | DBMET00728 | |
| 0.267 | 0.038 | 0.267 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.235 0.053 DBMET00728 0.158 0.112 DBMET00736 | ||
| 0.274 | 0.048 | 0.274 | Tyrosine 3 hydroxylase inhibitor | 0.274 0.049 DBMET00728 0.259 0.06 DBMET00736 | ||
| 0.233 | 0.009 | 0.242 | CF transmembrane conductance regulator agonist | 0.196 0.024 DBMET00728 0.242 0.008 DBMET00736 | DBMET00736 | |
| 0.237 | 0.015 | 0.237 | CDK/cyclin complex inhibitor | 0.082 0.067 DBMET00728 0.135 0.035 DBMET00736 | ||
| 0.224 | 0.004 | 0.224 | CDK3/cyclin E inhibitor | 0.206 0.005 DBMET00728 0.209 0.005 DBMET00736 | ||
| 0.242 | 0.022 | 0.242 | Cyclin-dependent kinase 7 inhibitor | 0.115 0.089 DBMET00728 0.156 0.055 DBMET00736 | ||
| 0.231 | 0.016 | 0.233 | Cathepsin H inhibitor | 0.233 0.016 DBMET00728 0.199 0.023 DBMET00736 | DBMET00728 | |
| 0.237 | 0.027 | 0.369 | Succinate dehydrogenase inhibitor | 0.369 0.005 DBMET00728 0.249 0.023 DBMET00736 | DBMET00728 | |
| 0.224 | 0.014 | 0.239 | MAP kinase 3 inhibitor | 0.202 0.023 DBMET00728 0.239 0.01 DBMET00736 | DBMET00736 | |
| 0.241 | 0.032 | 0.241 | Protein-tyrosine kinase Lyn inhibitor | 0.12 0.085 DBMET00736 | ||
| 0.271 | 0.063 | 0.304 | 5 Hydroxytryptamine uptake stimulant | 0.304 0.043 DBMET00728 0.257 0.074 DBMET00736 | DBMET00728 | |
| 0.223 | 0.02 | 0.223 | Chelator | 0.149 0.036 DBMET00728 0.131 0.044 DBMET00736 | ||
| 0.207 | 0.011 | 0.44 | Porphobilinogen synthase inhibitor | 0.44 0.004 DBMET00728 0.325 0.005 DBMET00736 | DBMET00728 | |
| 0.225 | 0.032 | 0.225 | 5 Hydroxytryptamine 3E antagonist | 0.176 0.117 DBMET00736 | ||
| 0.203 | 0.011 | 0.203 | Janus tyrosine kinase 3 inhibitor | |||
| 0.222 | 0.034 | 0.332 | Protein kinase stimulant | 0.23 0.032 DBMET00728 0.332 0.013 DBMET00736 | DBMET00736 | |
| 0.21 | 0.026 | 0.223 | Mannose-6-phosphate isomerase inhibitor | 0.218 0.022 DBMET00728 0.223 0.02 DBMET00736 | DBMET00736 | |
| 0.19 | 0.006 | 0.203 | Protein kinase C alpha inhibitor | 0.156 0.009 DBMET00728 0.203 0.005 DBMET00736 | DBMET00736 | |
| 0.202 | 0.02 | 0.558 | GABA C receptor agonist | 0.558 0.003 DBMET00728 0.241 0.014 DBMET00736 | DBMET00728 | |
| 0.249 | 0.067 | 0.349 | DNA synthesis inhibitor | 0.349 0.03 DBMET00728 0.34 0.032 DBMET00736 | DBMET00728 | |
| 0.176 | 0.011 | 0.176 | Phosphodiesterase 3A inhibitor | 0.114 0.024 DBMET00736 | ||
| 0.195 | 0.031 | 0.197 | GABA C receptor rho-2 antagonist | 0.197 0.03 DBMET00728 0.162 0.058 DBMET00736 | DBMET00728 | |
| 0.207 | 0.045 | 0.207 | Heat shock protein 90 alpha antagonist | 0.133 0.107 DBMET00728 | ||
| 0.17 | 0.008 | 0.17 | Cyclin E inhibitor | 0.076 0.034 DBMET00728 0.127 0.015 DBMET00736 | ||
| 0.183 | 0.021 | 0.2 | Fibroblast growth factor 1 antagonist | 0.2 0.016 DBMET00736 | DBMET00736 | |
| 0.194 | 0.04 | 0.194 | Death-associated protein kinase 2 inhibitor | |||
| 0.172 | 0.02 | 0.231 | GABA C receptor antagonist | 0.231 0.008 DBMET00728 0.155 0.027 DBMET00736 | DBMET00728 | |
| 0.21 | 0.059 | 0.21 | LIM domain kinase 1 inhibitor | 0.134 0.116 DBMET00728 0.147 0.101 DBMET00736 | ||
| 0.242 | 0.093 | 0.242 | 5 Hydroxytryptamine release stimulant | 0.24 0.094 DBMET00736 | ||
| 0.234 | 0.086 | 0.373 | Superoxide dismutase inhibitor | 0.373 0.032 DBMET00728 0.21 0.107 DBMET00736 | DBMET00728 | |
| 0.162 | 0.014 | 0.162 | NMDA 2 receptor antagonist | 0.14 0.019 DBMET00728 0.111 0.027 DBMET00736 | ||
| 0.165 | 0.018 | 0.176 | Ca2+-transporting ATPase inhibitor | 0.176 0.009 DBMET00728 0.156 0.03 DBMET00736 | DBMET00728 | |
| 0.158 | 0.014 | 0.158 | Inducible nitric-oxide synthase inhibitor | |||
| 0.169 | 0.026 | 0.169 | 5 Hydroxytryptamine 3A agonist | |||
| 0.162 | 0.019 | 0.234 | Creatine kinase inhibitor | 0.234 0.007 DBMET00728 0.15 0.024 DBMET00736 | DBMET00728 | |
| 0.196 | 0.056 | 0.196 | Src kinase inhibitor | 0.141 0.09 DBMET00736 | ||
| 0.176 | 0.038 | 0.176 | Aurora-B kinase inhibitor | 0.116 0.068 DBMET00736 | ||
| 0.191 | 0.052 | 0.191 | Protein kinase (CK1) gamma 3 inhibitor | 0.139 0.102 DBMET00728 | ||
| 0.145 | 0.008 | 0.145 | Protein kinase B beta inhibitor | 0.091 0.032 DBMET00736 | ||
| 0.156 | 0.019 | 0.156 | Protein kinase C delta inhibitor | 0.129 0.032 DBMET00728 0.153 0.02 DBMET00736 | ||
| 0.184 | 0.048 | 0.184 | Cyclin-dependent kinase 8 inhibitor | 0.144 0.086 DBMET00728 0.164 0.066 DBMET00736 | ||
| 0.138 | 0.005 | 0.138 | Heat shock protein 90 beta antagonist | 0.1 0.011 DBMET00728 0.091 0.014 DBMET00736 | ||
| 0.14 | 0.011 | 0.14 | Protein kinase B alpha inhibitor | 0.063 0.057 DBMET00736 | ||
| 0.181 | 0.053 | 0.188 | Arachidonic acid antagonist | 0.188 0.045 DBMET00728 0.169 0.066 DBMET00736 | DBMET00728 | |
| 0.139 | 0.013 | 0.139 | Bromodomain-containing protein 2 inhibitor | 0.086 0.063 DBMET00728 0.098 0.043 DBMET00736 | ||
| 0.168 | 0.043 | 0.168 | Protein kinase (CK1) delta inhibitor | |||
| 0.213 | 0.089 | 0.213 | MAP kinase kinase 3 inhibitor | |||
| 0.147 | 0.023 | 0.172 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.08 0.07 DBMET00728 0.172 0.015 DBMET00736 | DBMET00736 | |
| 0.132 | 0.009 | 0.132 | Transforming growth factor antagonist | 0.063 0.06 DBMET00728 0.131 0.009 DBMET00736 | ||
| 0.174 | 0.05 | 0.174 | Activin receptor-like kinase 2 inhibitor | 0.149 0.068 DBMET00736 | ||
| 0.14 | 0.018 | 0.14 | MAP kinase 10 inhibitor | 0.074 0.059 DBMET00736 | ||
| 0.14 | 0.019 | 0.14 | Protein kinase B gamma inhibitor | 0.089 0.039 DBMET00736 | ||
| 0.198 | 0.077 | 0.198 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.186 0.084 DBMET00728 | ||
| 0.13 | 0.011 | 0.13 | Cyclin E1 inhibitor | 0.094 0.021 DBMET00736 | ||
| 0.161 | 0.044 | 0.174 | MAP kinase kinase 4 inhibitor | 0.174 0.029 DBMET00728 0.156 0.051 DBMET00736 | DBMET00728 | |
| 0.12 | 0.004 | 0.12 | DNA topoisomerase IV inhibitor | |||
| 0.142 | 0.026 | 0.142 | Nitric-oxide synthase inhibitor | |||
| 0.129 | 0.014 | 0.129 | Janus tyrosine kinase 1 inhibitor | |||
| 0.137 | 0.022 | 0.137 | MAP kinase kinase 1 inhibitor | 0.134 0.024 DBMET00728 0.137 0.022 DBMET00736 | ||
| 0.205 | 0.09 | 0.242 | Cyclic AMP phosphodiesterase inhibitor | 0.242 0.068 DBMET00728 0.209 0.087 DBMET00736 | DBMET00728 | |
| 0.204 | 0.093 | 0.226 | RNA-directed DNA polymerase inhibitor | 0.201 0.098 DBMET00728 0.226 0.068 DBMET00736 | DBMET00736 | |
| 0.114 | 0.003 | 0.114 | Alpha 1d adrenoreceptor agonist | 0.072 0.007 DBMET00728 0.074 0.006 DBMET00736 | ||
| 0.132 | 0.024 | 0.132 | MAP kinase 14 inhibitor | |||
| 0.135 | 0.027 | 0.135 | Anabolic | 0.135 0.027 DBMET00728 0.134 0.028 DBMET00736 | ||
| 0.14 | 0.033 | 0.257 | UDP-glucose 4-epimerase inhibitor | 0.257 0.013 DBMET00728 0.221 0.016 DBMET00736 | DBMET00728 | |
| 0.123 | 0.018 | 0.253 | Glutamate (mGluR) agonist | 0.253 0.006 DBMET00728 0.065 0.041 DBMET00736 | DBMET00728 | |
| 0.16 | 0.056 | 0.244 | Cell wall synthesis inhibitor | 0.244 0.017 DBMET00728 0.197 0.031 DBMET00736 | DBMET00728 | |
| 0.136 | 0.032 | 0.258 | Adenylate kinase inhibitor | 0.258 0.009 DBMET00728 0.172 0.02 DBMET00736 | DBMET00728 | |
| 0.158 | 0.055 | 0.158 | Alkaline phosphatase inhibitor | 0.123 0.083 DBMET00728 | ||
| 0.171 | 0.069 | 0.171 | ATPase inhibitor | 0.153 0.096 DBMET00728 | ||
| 0.269 | 0.168 | 0.269 | MAP kinase kinase 6 inhibitor | |||
| 0.105 | 0.005 | 0.105 | Acetyl-CoA carboxylase inhibitor | 0.072 0.01 DBMET00728 0.078 0.009 DBMET00736 | ||
| 0.123 | 0.023 | 0.123 | Fibroblast growth factor 3 antagonist | 0.097 0.034 DBMET00736 | ||
| 0.14 | 0.041 | 0.14 | MAP kinase 9 inhibitor | |||
| 0.13 | 0.032 | 0.196 | GABA C receptor rho-1 antagonist | 0.196 0.009 DBMET00728 0.116 0.044 DBMET00736 | DBMET00728 | |
| 0.112 | 0.015 | 0.112 | DNA gyrase inhibitor | |||
| 0.117 | 0.019 | 0.117 | CDK1/cyclin B inhibitor | 0.085 0.031 DBMET00736 | ||
| 0.158 | 0.061 | 0.158 | Lck kinase inhibitor | |||
| 0.155 | 0.058 | 0.155 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | |||
| 0.162 | 0.066 | 0.232 | Hexokinase inhibitor | 0.232 0.021 DBMET00728 0.201 0.035 DBMET00736 | DBMET00728 | |
| 0.099 | 0.004 | 0.099 | Histamine H2 receptor agonist | 0.06 0.015 DBMET00728 0.065 0.012 DBMET00736 | ||
| 0.115 | 0.022 | 0.115 | Tyk2 inhibitor | |||
| 0.137 | 0.044 | 0.137 | Polo-like kinase-4 inhibitor | 0.101 0.076 DBMET00736 | ||
| 0.221 | 0.128 | 0.272 | Insulysin inhibitor | 0.272 0.078 DBMET00728 0.185 0.181 DBMET00736 | DBMET00728 | |
| 0.11 | 0.019 | 0.11 | CDC7 inhibitor | 0.089 0.03 DBMET00728 0.064 0.051 DBMET00736 | ||
| 0.125 | 0.035 | 0.15 | Prolactin inhibitor | 0.102 0.053 DBMET00728 0.15 0.022 DBMET00736 | DBMET00736 | |
| 0.094 | 0.005 | 0.094 | Plasma kallikrein inhibitor | |||
| 0.111 | 0.023 | 0.114 | mTOR complex 2 inhibitor | 0.088 0.052 DBMET00728 0.114 0.021 DBMET00736 | DBMET00736 | |
| 0.215 | 0.127 | 0.236 | Gastrin inhibitor | 0.236 0.096 DBMET00728 | DBMET00728 | |
| 0.111 | 0.025 | 0.111 | CDK1/cyclin B1 inhibitor | 0.095 0.03 DBMET00736 | ||
| 0.151 | 0.064 | 0.151 | Ca2+/calmodulin-dependent kinase II delta inhibitor | |||
| 0.21 | 0.124 | 0.228 | Transcription factor STAT inhibitor | 0.228 0.104 DBMET00728 0.189 0.154 DBMET00736 | DBMET00728 | |
| 0.152 | 0.066 | 0.152 | Protein kinase (CK1) inhibitor | |||
| 0.139 | 0.054 | 0.139 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.097 0.088 DBMET00736 | ||
| 0.185 | 0.099 | 0.185 | EphB2 antagonist | |||
| 0.139 | 0.053 | 0.139 | Abl kinase inhibitor | 0.097 0.088 DBMET00736 | ||
| 0.179 | 0.095 | 0.179 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.15 0.132 DBMET00736 | ||
| 0.092 | 0.008 | 0.226 | Glutamate (mGluR group II) agonist | 0.226 0.004 DBMET00728 0.054 0.014 DBMET00736 | DBMET00728 | |
| 0.102 | 0.018 | 0.541 | Alcohol oxidase inhibitor | 0.541 0.003 DBMET00728 0.129 0.013 DBMET00736 | DBMET00728 | |
| 0.089 | 0.005 | 0.089 | Acetylcholine M4 receptor agonist | |||
| 0.135 | 0.051 | 0.241 | Protein kinase (CK2) alpha inhibitor | 0.241 0.017 DBMET00728 0.115 0.065 DBMET00736 | DBMET00728 | |
| 0.119 | 0.036 | 0.119 | Hepatocyte growth factor antagonist | |||
| 0.143 | 0.06 | 0.247 | M17 leucyl aminopeptidase inhibitor | 0.247 0.021 DBMET00728 | DBMET00728 | |
| 0.09 | 0.007 | 0.215 | Glutamate (mGluR2) agonist | 0.215 0.004 DBMET00728 0.05 0.014 DBMET00736 | DBMET00728 | |
| 0.087 | 0.004 | 0.087 | Acetyl-CoA carboxylase 1 inhibitor | 0.018 0.013 DBMET00728 | ||
| 0.126 | 0.044 | 0.314 | Xanthine oxidase inhibitor | 0.314 0.007 DBMET00728 0.172 0.027 DBMET00736 | DBMET00728 | |
| 0.113 | 0.031 | 0.113 | Janus tyrosine kinase 2 inhibitor | |||
| 0.096 | 0.016 | 0.096 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.086 0.027 DBMET00728 0.076 0.045 DBMET00736 | ||
| 0.091 | 0.012 | 0.091 | Proto-oncogene tyrosine-protein kinase Met inhibitor | |||
| 0.148 | 0.07 | 0.148 | Growth factor antagonist | |||
| 0.173 | 0.096 | 0.173 | Focal adhesion kinase 2 inhibitor | |||
| 0.097 | 0.019 | 0.097 | Carbonic anhydrase stimulant | 0.079 0.026 DBMET00728 0.068 0.033 DBMET00736 | ||
| 0.176 | 0.099 | 0.218 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.214 0.062 DBMET00728 0.218 0.059 DBMET00736 | DBMET00736 | |
| 0.286 | 0.209 | 0.357 | Caspase 9 stimulant | 0.357 0.14 DBMET00736 | DBMET00736 | |
| 0.208 | 0.132 | 0.208 | Lipoxygenase inhibitor | 0.19 0.15 DBMET00728 0.187 0.154 DBMET00736 | ||
| 0.128 | 0.053 | 0.198 | Cystathionine beta-synthase inhibitor | 0.198 0.025 DBMET00728 0.108 0.069 DBMET00736 | DBMET00728 | |
| 0.09 | 0.015 | 0.09 | Exportin-1 inhibitor | 0.068 0.048 DBMET00728 0.066 0.052 DBMET00736 | ||
| 0.143 | 0.068 | 0.143 | Tyrosine-protein kinase receptor antagonist | |||
| 0.112 | 0.038 | 0.224 | Triose-phosphate isomerase inhibitor | 0.224 0.009 DBMET00728 0.163 0.017 DBMET00736 | DBMET00728 | |
| 0.101 | 0.027 | 0.101 | Syk tyrosine kinase inhibitor | 0.087 0.036 DBMET00728 0.084 0.037 DBMET00736 | ||
| 0.118 | 0.045 | 0.118 | MAP kinase 8 inhibitor | 0.101 0.06 DBMET00728 | ||
| 0.093 | 0.021 | 0.192 | Biliverdin reductase inhibitor | 0.192 0.006 DBMET00728 0.091 0.021 DBMET00736 | DBMET00728 | |
| 0.107 | 0.037 | 0.171 | NADH dehydrogenase inhibitor | 0.171 0.014 DBMET00728 0.146 0.018 DBMET00736 | DBMET00728 | |
| 0.083 | 0.013 | 0.083 | Protein kinase C theta inhibitor | |||
| 0.133 | 0.063 | 0.14 | MAP kinase kinase inhibitor | 0.131 0.064 DBMET00728 0.14 0.057 DBMET00736 | DBMET00736 | |
| 0.085 | 0.016 | 0.085 | Phosphodiesterase II inhibitor | |||
| 0.082 | 0.013 | 0.082 | Cyclin A1 inhibitor | 0.064 0.03 DBMET00728 0.062 0.034 DBMET00736 | ||
| 0.109 | 0.041 | 0.109 | Acetylcholine agonist | |||
| 0.088 | 0.02 | 0.088 | Aryl hydrocarbon receptor antagonist | |||
| 0.071 | 0.004 | 0.071 | Acetyl-CoA carboxylase 2 inhibitor | 0.023 0.015 DBMET00728 0.044 0.008 DBMET00736 | ||
| 0.1 | 0.035 | 0.104 | Myeloperoxidase inhibitor | 0.099 0.037 DBMET00728 0.104 0.031 DBMET00736 | DBMET00736 | |
| 0.105 | 0.041 | 0.105 | Pim-3 kinase inhibitor | 0.08 0.078 DBMET00728 0.079 0.078 DBMET00736 | ||
| 0.078 | 0.015 | 0.078 | Kallikrein inhibitor | |||
| 0.077 | 0.015 | 0.077 | Phosphodiesterase 2A inhibitor | |||
| 0.072 | 0.011 | 0.072 | Alpha 1b adrenoreceptor agonist | 0.047 0.043 DBMET00736 | ||
| 0.102 | 0.041 | 0.102 | Leucine-rich repeat kinase 2 inhibitor | |||
| 0.079 | 0.02 | 0.128 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.075 0.023 DBMET00728 0.128 0.01 DBMET00736 | DBMET00736 | |
| 0.087 | 0.029 | 0.095 | MAP kinase kinase 7 inhibitor | 0.092 0.021 DBMET00728 0.095 0.018 DBMET00736 | DBMET00736 | |
| 0.1 | 0.041 | 0.1 | ALK inhibitor | |||
| 0.097 | 0.039 | 0.233 | Glutamate receptor agonist | 0.233 0.008 DBMET00728 0.086 0.048 DBMET00736 | DBMET00728 | |
| 0.085 | 0.028 | 0.085 | CDK2/cyclin E inhibitor | 0.054 0.049 DBMET00736 | ||
| 0.152 | 0.097 | 0.159 | 3C-like protease (Human coronavirus) inhibitor | 0.159 0.087 DBMET00728 | DBMET00728 | |
| 0.111 | 0.056 | 0.111 | Check point kinase 2 inhibitor | 0.091 0.073 DBMET00728 | ||
| 0.107 | 0.053 | 0.107 | Insulin receptor antagonist | |||
| 0.172 | 0.119 | 0.172 | Aryl hydrocarbon receptor agonist | |||
| 0.138 | 0.085 | 0.153 | Adenylate cyclase stimulant | 0.123 0.117 DBMET00728 0.153 0.058 DBMET00736 | DBMET00736 | |
| 0.117 | 0.066 | 0.117 | Transcription factor STAT6 inhibitor | |||
| 0.108 | 0.057 | 0.216 | Protein kinase (CK2) inhibitor | 0.216 0.016 DBMET00728 0.101 0.063 DBMET00736 | DBMET00728 | |
| 0.07 | 0.019 | 0.07 | Acetylcholine M1 receptor agonist | |||
| 0.076 | 0.025 | 0.076 | Cyclin-dependent kinase 6 inhibitor | 0.055 0.047 DBMET00736 | ||
| 0.066 | 0.015 | 0.07 | Secretase gamma inhibitor | 0.07 0.013 DBMET00736 | DBMET00736 | |
| 0.069 | 0.018 | 0.087 | Dihydroorotate oxidase inhibitor | 0.087 0.008 DBMET00728 0.056 0.035 DBMET00736 | DBMET00728 | |
| 0.098 | 0.048 | 0.098 | Insulin growth factor antagonist | 0.076 0.073 DBMET00736 | ||
| 0.108 | 0.059 | 0.108 | MAP kinase kinase kinase inhibitor | 0.095 0.071 DBMET00736 | ||
| 0.065 | 0.017 | 0.135 | Glutamate (mGluR group III) agonist | 0.135 0.005 DBMET00728 0.056 0.02 DBMET00736 | DBMET00728 | |
| 0.061 | 0.013 | 0.061 | Geranyltranstransferase inhibitor | 0.061 0.013 DBMET00728 0.054 0.019 DBMET00736 | ||
| 0.073 | 0.025 | 0.073 | Acetylcholine muscarinic agonist | |||
| 0.075 | 0.028 | 0.241 | Xanthine dehydrogenase inhibitor | 0.241 0.004 DBMET00728 0.114 0.012 DBMET00736 | DBMET00728 | |
| 0.087 | 0.04 | 0.087 | Rho-associated kinase I inhibitor | |||
| 0.102 | 0.056 | 0.107 | Pim-1 kinase inhibitor | 0.107 0.052 DBMET00728 | DBMET00728 | |
| 0.1 | 0.054 | 0.215 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.215 0.014 DBMET00728 0.173 0.021 DBMET00736 | DBMET00728 | |
| 0.109 | 0.062 | 0.109 | Granulocyte macrophage colony stimulating factor antagonist | |||
| 0.093 | 0.047 | 0.093 | Insulin like growth factor 1 antagonist | |||
| 0.116 | 0.07 | 0.116 | Tyrosine-protein kinase receptor FLT3 inhibitor | |||
| 0.148 | 0.102 | 0.148 | TRKC antagonist | |||
| 0.072 | 0.026 | 0.072 | Cyclin D1 inhibitor | 0.068 0.031 DBMET00736 | ||
| 0.052 | 0.006 | 0.097 | Methionyl aminopeptidase 2 inhibitor | 0.097 0.004 DBMET00728 0.041 0.009 DBMET00736 | DBMET00728 | |
| 0.101 | 0.057 | 0.161 | Electrolyte absorption antagonist | 0.161 0.016 DBMET00728 | DBMET00728 | |
| 0.065 | 0.022 | 0.065 | Lysine-specific demethylase 1A inhibitor | 0.061 0.026 DBMET00736 | ||
| 0.134 | 0.09 | 0.134 | Pregnane X receptor agonist | |||
| 0.077 | 0.033 | 0.077 | Cyclin A inhibitor | 0.055 0.049 DBMET00736 | ||
| 0.089 | 0.046 | 0.11 | D-Ala-D-Ala ligase inhibitor | 0.11 0.02 DBMET00728 0.083 0.06 DBMET00736 | DBMET00728 | |
| 0.136 | 0.092 | 0.151 | Heat shock protein 70 antagonist | 0.151 0.043 DBMET00728 0.129 0.126 DBMET00736 | DBMET00728 | |
| 0.078 | 0.035 | 0.078 | Fibroblast growth factor 2 antagonist | 0.074 0.038 DBMET00736 | ||
| 0.079 | 0.036 | 0.079 | Orexin receptor 1 antagonist | |||
| 0.088 | 0.045 | 0.088 | Estrogen-related receptor beta agonist | 0.081 0.064 DBMET00728 0.081 0.065 DBMET00736 | ||
| 0.06 | 0.018 | 0.06 | Adenylate cyclase 1 inhibitor | |||
| 0.055 | 0.013 | 0.244 | Nicotinic acid receptor agonist | 0.244 0.003 DBMET00728 0.051 0.014 DBMET00736 | DBMET00728 | |
| 0.113 | 0.071 | 0.113 | Protein kinase (CK1) gamma 2 inhibitor | |||
| 0.084 | 0.042 | 0.148 | GABA aminotransferase inhibitor | 0.148 0.008 DBMET00728 0.081 0.045 DBMET00736 | DBMET00728 | |
| 0.106 | 0.065 | 0.162 | DOPA decarboxylase inhibitor | 0.162 0.016 DBMET00728 0.112 0.055 DBMET00736 | DBMET00728 | |
| 0.074 | 0.033 | 0.101 | Glutamate (mGluR6) antagonist | 0.101 0.01 DBMET00728 0.072 0.036 DBMET00736 | DBMET00728 | |
| 0.044 | 0.004 | 0.091 | Nicotinic acid receptor 2 antagonist | 0.091 0.002 DBMET00728 0.042 0.005 DBMET00736 | DBMET00728 | |
| 0.101 | 0.061 | 0.101 | mTOR complex 1 inhibitor | |||
| 0.072 | 0.033 | 0.111 | Carbamoyl phosphate synthetase inhibitor | 0.099 0.021 DBMET00728 0.111 0.018 DBMET00736 | DBMET00736 | |
| 0.063 | 0.024 | 0.063 | Transforming growth factor beta 1 antagonist | 0.048 0.036 DBMET00736 | ||
| 0.051 | 0.013 | 0.088 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.088 0.003 DBMET00728 0.046 0.02 DBMET00736 | DBMET00728 | |
| 0.061 | 0.023 | 0.061 | Purinergic P2X antagonist | |||
| 0.074 | 0.036 | 0.074 | Cyclin A2 inhibitor | 0.057 0.05 DBMET00736 | ||
| 0.125 | 0.088 | 0.125 | Nav1.6 sodium channel blocker | |||
| 0.081 | 0.043 | 0.206 | Glutamate decarboxylase inhibitor | 0.206 0.006 DBMET00728 0.093 0.034 DBMET00736 | DBMET00728 | |
| 0.153 | 0.116 | 0.211 | I kappa B kinase epsilon inhibitor | 0.211 0.062 DBMET00728 0.165 0.104 DBMET00736 | DBMET00728 | |
| 0.05 | 0.013 | 0.05 | MAP3K5 inhibitor | 0.046 0.017 DBMET00736 | ||
| 0.074 | 0.037 | 0.074 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.127 | 0.09 | 0.127 | Protein kinase (CK1) gamma 1 inhibitor | |||
| 0.12 | 0.084 | 0.12 | Sodium channel (voltage-gated) blocker | 0.12 0.084 DBMET00736 | ||
| 0.123 | 0.087 | 0.123 | Protein kinase (CK1) gamma inhibitor | |||
| 0.068 | 0.034 | 0.068 | Transcription factor RelA inhibitor | |||
| 0.046 | 0.012 | 0.08 | Glutamate (mGluR4) agonist | 0.08 0.005 DBMET00728 0.04 0.016 DBMET00736 | DBMET00728 | |
| 0.127 | 0.094 | 0.127 | Cytidine deaminase inhibitor | 0.113 0.109 DBMET00736 | ||
| 0.096 | 0.063 | 0.099 | Lanosterol 14 alpha demethylase inhibitor | 0.099 0.057 DBMET00736 | DBMET00736 | |
| 0.248 | 0.215 | 0.538 | Cyclophilin D inhibitor | 0.538 0.04 DBMET00728 0.491 0.053 DBMET00736 | DBMET00728 | |
| 0.116 | 0.084 | 0.235 | Amylase inhibitor | 0.135 0.072 DBMET00728 0.235 0.033 DBMET00736 | DBMET00736 | |
| 0.034 | 0.002 | 0.034 | 4-Hydroxyphenylpyruvate dioxygenase inhibitor | 0.026 0.003 DBMET00728 0.028 0.003 DBMET00736 | ||
| 0.075 | 0.044 | 0.169 | Phosphofructokinase-1 inhibitor | 0.169 0.015 DBMET00728 0.143 0.019 DBMET00736 | DBMET00728 | |
| 0.179 | 0.147 | 0.179 | Streptokinase A inhibitor | |||
| 0.066 | 0.036 | 0.066 | TRPA1 antagonist | |||
| 0.058 | 0.028 | 0.177 | Aconitate hydratase inhibitor | 0.177 0.004 DBMET00728 0.07 0.018 DBMET00736 | DBMET00728 | |
| 0.077 | 0.047 | 0.174 | Glutamate dehydrogenase inhibitor | 0.174 0.012 DBMET00728 0.095 0.033 DBMET00736 | DBMET00728 | |
| 0.054 | 0.024 | 0.054 | Phosphodiesterase X inhibitor | |||
| 0.054 | 0.024 | 0.054 | Phosphodiesterase 10A inhibitor | |||
| 0.157 | 0.128 | 0.203 | Neurotrophic factor enhancer | 0.203 0.074 DBMET00736 | DBMET00736 | |
| 0.101 | 0.071 | 0.101 | Vascular endothelial growth factor 2 antagonist | |||
| 0.134 | 0.105 | 0.134 | Polo-like kinase-3 inhibitor | |||
| 0.071 | 0.041 | 0.077 | Glutamate (mGluR7) antagonist | 0.077 0.032 DBMET00728 | DBMET00728 | |
| 0.058 | 0.029 | 0.058 | Histamine agonist | |||
| 0.111 | 0.082 | 0.139 | c-Src kinase inhibitor | 0.139 0.062 DBMET00736 | DBMET00736 | |
| 0.106 | 0.077 | 0.106 | Vascular endothelial growth factor antagonist | |||
| 0.037 | 0.009 | 0.037 | MAP3K8 inhibitor | 0.029 0.021 DBMET00728 0.032 0.015 DBMET00736 | ||
| 0.076 | 0.047 | 0.076 | Polo-like kinase-2 inhibitor | |||
| 0.16 | 0.131 | 0.16 | Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor | |||
| 0.074 | 0.047 | 0.097 | Glycine receptor agonist | 0.097 0.023 DBMET00728 | DBMET00728 | |
| 0.108 | 0.08 | 0.108 | TRKA antagonist | 0.102 0.087 DBMET00736 | ||
| 0.053 | 0.026 | 0.077 | Glucose-6-phosphate isomerase inhibitor | 0.062 0.017 DBMET00728 0.077 0.01 DBMET00736 | DBMET00736 | |
| 0.201 | 0.175 | 0.29 | Vasodilator, peripheral | 0.25 0.127 DBMET00728 0.29 0.102 DBMET00736 | DBMET00736 | |
| 0.076 | 0.05 | 0.099 | GABA B receptor agonist | 0.099 0.017 DBMET00728 0.074 0.055 DBMET00736 | DBMET00728 | |
| 0.171 | 0.144 | 0.213 | Spasmolytic | 0.192 0.127 DBMET00728 0.213 0.109 DBMET00736 | DBMET00736 | |
| 0.101 | 0.075 | 0.145 | Protein kinase C gamma inhibitor | 0.145 0.035 DBMET00728 0.136 0.041 DBMET00736 | DBMET00728 | |
| 0.111 | 0.085 | 0.111 | TRKB antagonist | |||
| 0.074 | 0.049 | 0.115 | Aminopeptidase I inhibitor | 0.115 0.021 DBMET00728 0.073 0.05 DBMET00736 | DBMET00728 | |
| 0.035 | 0.011 | 0.035 | 5 Hydroxytryptamine 6 agonist | |||
| 0.038 | 0.015 | 0.038 | ATR kinase inhibitor | |||
| 0.147 | 0.124 | 0.147 | MAP kinase kinase 2 inhibitor | |||
| 0.027 | 0.005 | 0.059 | Nicotinic acid receptor 1 antagonist | 0.059 0.002 DBMET00728 0.023 0.006 DBMET00736 | DBMET00728 | |
| 0.122 | 0.1 | 0.154 | Farnesoid X receptor antagonist | 0.154 0.048 DBMET00728 0.127 0.089 DBMET00736 | DBMET00728 | |
| 0.059 | 0.037 | 0.148 | Argininosuccinate synthase inhibitor | 0.148 0.012 DBMET00728 0.074 0.028 DBMET00736 | DBMET00728 | |
| 0.058 | 0.037 | 0.058 | Pregnane X receptor antagonist | 0.057 0.037 DBMET00728 | ||
| 0.119 | 0.099 | 0.122 | Sphingosine 1-phosphate receptor 2 antagonist | 0.122 0.092 DBMET00728 0.117 0.106 DBMET00736 | DBMET00728 | |
| 0.083 | 0.062 | 0.112 | NMDA receptor antagonist | 0.112 0.039 DBMET00728 0.08 0.065 DBMET00736 | DBMET00728 | |
| 0.092 | 0.072 | 0.092 | Cyclin-dependent kinase 9 inhibitor | |||
| 0.05 | 0.03 | 0.051 | Dopamine beta hydroxylase inhibitor | 0.051 0.028 DBMET00728 0.051 0.028 DBMET00736 | DBMET00736 | |
| 0.033 | 0.014 | 0.033 | Nicotinic alpha4beta2 receptor agonist | |||
| 0.181 | 0.163 | 0.202 | Transcription factor STAT3 inhibitor | 0.202 0.13 DBMET00728 | DBMET00728 | |
| 0.066 | 0.048 | 0.066 | Nav1.7 sodium channel blocker | 0.062 0.055 DBMET00736 | ||
| 0.074 | 0.056 | 0.09 | Na+ K+ transporting ATPase inhibitor | 0.09 0.04 DBMET00736 | DBMET00736 | |
| 0.055 | 0.037 | 0.124 | Acyl-CoA dehydrogenase inhibitor | 0.124 0.012 DBMET00728 0.073 0.025 DBMET00736 | DBMET00728 | |
| 0.176 | 0.158 | 0.176 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.054 | 0.037 | 0.055 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.055 0.036 DBMET00728 0.053 0.038 DBMET00736 | DBMET00728 | |
| 0.222 | 0.205 | 0.301 | Antibacterial | 0.301 0.134 DBMET00728 0.245 0.182 DBMET00736 | DBMET00728 | |
| 0.08 | 0.064 | 0.08 | CC chemokine 5 receptor agonist | |||
| 0.054 | 0.038 | 0.076 | Myc inhibitor | 0.076 0.015 DBMET00728 | DBMET00728 | |
| 0.029 | 0.014 | 0.029 | Glucosylceramidase stimulant | |||
| 0.061 | 0.046 | 0.068 | Phosphodiesterase 1C inhibitor | 0.068 0.033 DBMET00736 | DBMET00736 | |
| 0.094 | 0.079 | 0.096 | Beta glucuronidase inhibitor | 0.096 0.077 DBMET00728 | DBMET00728 | |
| 0.064 | 0.05 | 0.064 | Orexin receptor antagonist | |||
| 0.13 | 0.116 | 0.205 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.205 0.016 DBMET00728 | DBMET00728 | |
| 0.14 | 0.125 | 0.14 | Pyruvate kinase inhibitor | |||
| 0.083 | 0.068 | 0.098 | Granulocyte macrophage colony stimulating factor agonist | 0.09 0.052 DBMET00728 0.098 0.038 DBMET00736 | DBMET00736 | |
| 0.128 | 0.114 | 0.155 | Interferon gamma antagonist | 0.155 0.071 DBMET00728 0.132 0.107 DBMET00736 | DBMET00728 | |
| 0.067 | 0.053 | 0.235 | Histidine decarboxylase inhibitor | 0.235 0.01 DBMET00728 0.211 0.012 DBMET00736 | DBMET00728 | |
| 0.028 | 0.014 | 0.036 | Thymidine phosphorylase inhibitor | 0.024 0.023 DBMET00728 0.036 0.008 DBMET00736 | DBMET00736 | |
| 0.056 | 0.043 | 0.056 | Botulinum neurotoxin type A inhibitor | |||
| 0.021 | 0.008 | 0.021 | Alpha 2a adrenoreceptor agonist | |||
| 0.041 | 0.028 | 0.041 | Glutamate (mGluR1a) antagonist | |||
| 0.067 | 0.054 | 0.077 | Protein kinase C beta inhibitor | 0.076 0.036 DBMET00728 0.077 0.034 DBMET00736 | DBMET00736 | |
| 0.067 | 0.055 | 0.067 | Secretase beta inhibitor | |||
| 0.031 | 0.018 | 0.031 | Cyclin E2 inhibitor | 0.028 0.021 DBMET00736 | ||
| 0.108 | 0.096 | 0.124 | Glycogen synthase kinase-3 alpha inhibitor | 0.124 0.082 DBMET00728 | DBMET00728 | |
| 0.024 | 0.012 | 0.024 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | |||
| 0.075 | 0.064 | 0.075 | Acetylcholine nicotinic agonist | |||
| 0.042 | 0.033 | 0.187 | Guanylate cyclase stimulant | 0.187 0.004 DBMET00728 0.041 0.036 DBMET00736 | DBMET00728 | |
| 0.037 | 0.028 | 0.037 | Potassium channel Kv1.1 blocker | |||
| 0.19 | 0.181 | 0.32 | Angiogenesis inhibitor | 0.32 0.083 DBMET00736 | DBMET00736 | |
| 0.091 | 0.081 | 0.142 | Carbonic anhydrase XV inhibitor | 0.142 0.034 DBMET00728 0.133 0.038 DBMET00736 | DBMET00728 | |
| 0.054 | 0.045 | 0.054 | Fatty acid synthase inhibitor | |||
| 0.057 | 0.048 | 0.057 | Phosphodiesterase 1A inhibitor | |||
| 0.085 | 0.076 | 0.101 | Protein kinase C zeta inhibitor | 0.085 0.075 DBMET00728 0.101 0.049 DBMET00736 | DBMET00736 | |
| 0.032 | 0.025 | 0.056 | Protein kinase (CK2) beta inhibitor | 0.056 0.005 DBMET00728 0.035 0.019 DBMET00736 | DBMET00728 | |
| 0.043 | 0.035 | 0.043 | Poly(ADP-ribose) polymerase inhibitor | |||
| 0.032 | 0.024 | 0.048 | Glutamate (mGluR3) agonist | 0.048 0.005 DBMET00728 0.033 0.02 DBMET00736 | DBMET00728 | |
| 0.077 | 0.071 | 0.077 | Histamine H2 receptor antagonist | |||
| 0.024 | 0.018 | 0.024 | Phosphodiesterase 9A inhibitor | |||
| 0.108 | 0.102 | 0.122 | DNA repair enzyme inhibitor | 0.108 0.1 DBMET00728 0.122 0.068 DBMET00736 | DBMET00736 | |
| 0.025 | 0.019 | 0.025 | Thyroid hormone agonist | |||
| 0.013 | 0.007 | 0.037 | Egl nine homolog 3 inhibitor | 0.037 0.003 DBMET00728 | DBMET00728 | |
| 0.036 | 0.031 | 0.061 | Glutamate (mGluR8) agonist | 0.061 0.007 DBMET00728 0.042 0.02 DBMET00736 | DBMET00728 | |
| 0.037 | 0.032 | 0.037 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.033 | 0.029 | 0.033 | Orexin receptor 2 antagonist | |||
| 0.021 | 0.017 | 0.022 | Glutamate (mGluR1a) agonist | 0.022 0.016 DBMET00728 | DBMET00728 | |
| 0.024 | 0.02 | 0.024 | Vanilloid 2 agonist | 0.024 0.02 DBMET00728 | ||
| 0.022 | 0.018 | 0.022 | Phosphodiesterase IX inhibitor | |||
| 0.008 | 0.004 | 0.008 | Integrin alpha5beta6 antagonist | |||
| 0.039 | 0.035 | 0.058 | Angiotensin AT1 receptor antagonist | 0.058 0.008 DBMET00728 0.042 0.029 DBMET00736 | DBMET00728 | |
| 0.078 | 0.074 | 0.078 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | |||
| 0.055 | 0.052 | 0.099 | Purinergic P2X1 antagonist | 0.099 0.017 DBMET00728 0.06 0.043 DBMET00736 | DBMET00728 | |
| 0.038 | 0.036 | 0.054 | Kainate receptor agonist | 0.054 0.01 DBMET00728 | DBMET00728 | |
| 0.04 | 0.038 | 0.04 | Oleamide hydrolase inhibitor | |||
| 0.067 | 0.065 | 0.071 | Adenosine A3 receptor antagonist | 0.071 0.056 DBMET00736 | DBMET00736 | |
| 0.096 | 0.094 | 0.158 | Cholesterol synthesis inhibitor | 0.158 0.041 DBMET00728 | DBMET00728 | |
| 0.082 | 0.08 | 0.156 | Aminopeptidase B inhibitor | 0.156 0.035 DBMET00728 0.09 0.072 DBMET00736 | DBMET00728 | |
| 0.016 | 0.014 | 0.016 | CC chemokine 9 receptor antagonist | 0.016 0.013 DBMET00728 | ||
| 0.055 | 0.053 | 0.055 | Purinergic P2 antagonist | |||
| 0.177 | 0.176 | 0.177 | 12-Lipoxygenase inhibitor | |||
| 0.1 | 0.099 | 0.144 | Aldehyde dehydrogenase inhibitor | 0.144 0.051 DBMET00728 0.13 0.062 DBMET00736 | DBMET00728 | |
| 0.032 | 0.031 | 0.306 | Nicotinic acid receptor 2 agonist | 0.306 0.003 DBMET00728 0.037 0.023 DBMET00736 | DBMET00728 | |
| 0.027 | 0.026 | 0.027 | Nicotinic alpha3beta4 receptor agonist | |||
| 0.031 | 0.03 | 0.031 | Transforming growth factor beta 2 antagonist | |||
| 0.017 | 0.019 | 0.141 | Guanylate cyclase 1 stimulant | 0.141 0.004 DBMET00728 | DBMET00728 | |
| 0.058 | 0.06 | 0.124 | Phenylalanine 4-hydroxylase inhibitor | 0.124 0.017 DBMET00728 0.069 0.047 DBMET00736 | DBMET00728 | |
| 0.013 | 0.017 | 0.023 | Carbonic anhydrase X inhibitor | 0.023 0.006 DBMET00728 | DBMET00728 | |
| 0.013 | 0.017 | 0.023 | Carbonic anhydrase VIII inhibitor | 0.023 0.006 DBMET00728 | DBMET00728 | |
| 0.015 | 0.019 | 0.017 | Telomerase stimulant | 0.017 0.012 DBMET00736 | DBMET00736 | |
| 0.089 | 0.094 | 0.122 | Nav1.4 sodium channel blocker | 0.122 0.05 DBMET00736 | DBMET00736 | |
| 0.048 | 0.053 | 0.057 | EphB4 antagonist | 0.057 0.041 DBMET00736 | DBMET00736 | |
| 0.022 | 0.027 | 0.038 | Uridine phosphorylase inhibitor | 0.032 0.016 DBMET00728 0.038 0.013 DBMET00736 | DBMET00736 | |
| 0.081 | 0.087 | 0.101 | Glutamate release inhibitor | 0.086 0.072 DBMET00728 0.101 0.041 DBMET00736 | DBMET00736 | |
| 0.059 | 0.066 | 0.062 | MAP kinase kinase 8 inhibitor | 0.062 0.06 DBMET00736 | DBMET00736 | |
| 0.035 | 0.042 | 0.045 | Guanylate cyclase inhibitor | 0.045 0.027 DBMET00728 | DBMET00728 | |
| 0.186 | 0.195 | 0.241 | Vasodilator, coronary | 0.219 0.165 DBMET00728 0.241 0.143 DBMET00736 | DBMET00736 | |
| 0.027 | 0.035 | 0.069 | Fumarate hydratase inhibitor | 0.069 0.009 DBMET00728 0.037 0.021 DBMET00736 | DBMET00728 | |
| 0.009 | 0.019 | 0.011 | CD80 antagonist | 0.011 0.007 DBMET00728 | DBMET00728 | |
| 0.01 | 0.021 | 0.037 | Egl nine homolog 1 inhibitor | 0.037 0.004 DBMET00728 | DBMET00728 | |
| 0.04 | 0.051 | 0.093 | Ornithine carbamoyltransferase inhibitor | 0.093 0.018 DBMET00728 0.058 0.033 DBMET00736 | DBMET00728 | |
| 0.028 | 0.039 | 0.049 | Angiotensin II receptor antagonist | 0.049 0.007 DBMET00728 0.031 0.03 DBMET00736 | DBMET00728 | |
| 0.007 | 0.02 | 0.018 | Glutamate (mGluR6) agonist | 0.018 0.004 DBMET00728 | DBMET00728 | |
| 0.029 | 0.042 | 0.066 | Glutamate (mGluR3) antagonist | 0.066 0.007 DBMET00728 0.036 0.026 DBMET00736 | DBMET00728 | |
| 0.017 | 0.031 | 0.027 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.027 0.02 DBMET00736 | DBMET00736 | |
| 0.02 | 0.035 | 0.027 | Glutamate (mGluR1) agonist | 0.027 0.013 DBMET00728 | DBMET00728 | |
| 0.035 | 0.05 | 0.046 | Nerve growth factor antagonist | 0.046 0.023 DBMET00728 | DBMET00728 | |
| 0.05 | 0.067 | 0.108 | NMDA receptor agonist | 0.108 0.016 DBMET00728 | DBMET00728 | |
| 0.008 | 0.027 | 0.017 | Adenosine A2a receptor agonist | 0.017 0.009 DBMET00736 | DBMET00736 | |
| 0.016 | 0.035 | 0.032 | Kynurenine 3 monooxygenase inhibitor | 0.032 0.014 DBMET00728 | DBMET00728 | |
| 0.133 | 0.152 | 0.144 | Neurotensin receptor agonist | 0.144 0.117 DBMET00728 | DBMET00728 | |
| 0.015 | 0.034 | 0.019 | Methylmalonyl-CoA mutase inhibitor | 0.019 0.011 DBMET00728 | DBMET00728 | |
| 0.112 | 0.131 | 0.189 | MAP3K9 inhibitor | 0.139 0.079 DBMET00728 0.189 0.021 DBMET00736 | DBMET00736 | |
| 0.078 | 0.098 | 0.091 | Falcipain 3 inhibitor | 0.091 0.08 DBMET00728 | DBMET00728 | |
| 0.034 | 0.056 | 0.039 | CF transmembrane conductance regulator antagonist | 0.038 0.033 DBMET00728 0.039 0.031 DBMET00736 | DBMET00736 | |
| 0.042 | 0.064 | 0.068 | Alpha-mannosidase inhibitor | 0.049 0.045 DBMET00728 0.068 0.018 DBMET00736 | DBMET00736 | |
| 0.01 | 0.033 | 0.017 | Adenosine A2 receptor agonist | 0.017 0.01 DBMET00736 | DBMET00736 | |
| 0.104 | 0.128 | 0.162 | Diuretic | 0.162 0.067 DBMET00728 | DBMET00728 | |
| 0.016 | 0.04 | 0.021 | Retinoid X beta receptor antagonist | 0.021 0.013 DBMET00728 | DBMET00728 | |
| 0.115 | 0.141 | 0.145 | Sphingosine 1-phosphate receptor 5 antagonist | 0.145 0.07 DBMET00728 | DBMET00728 | |
| 0.129 | 0.156 | 0.17 | Phospholipase C inhibitor | 0.17 0.073 DBMET00728 0.159 0.089 DBMET00736 | DBMET00728 | |
| 0.038 | 0.066 | 0.054 | Topoisomerase II beta inhibitor | 0.054 0.028 DBMET00728 0.052 0.03 DBMET00736 | DBMET00728 | |
| 0.015 | 0.044 | 0.026 | Neuraminidase (Influenza B) inhibitor | 0.026 0.006 DBMET00728 | DBMET00728 | |
| 0.036 | 0.066 | 0.056 | Lysophosphatidic acid 3 receptor antagonist | 0.056 0.027 DBMET00728 | DBMET00728 | |
| 0.023 | 0.052 | 0.051 | Farnesoid X receptor agonist | 0.051 0.014 DBMET00728 | DBMET00728 | |
| 0.017 | 0.047 | 0.03 | Sodium/glucose cotransporter 2 inhibitor | 0.03 0.013 DBMET00736 | DBMET00736 | |
| 0.06 | 0.09 | 0.091 | Macrophage migration inhibitory factor inhibitor | 0.091 0.04 DBMET00728 | DBMET00728 | |
| 0.027 | 0.059 | 0.039 | Membrane dipeptidase inhibitor | 0.039 0.028 DBMET00728 | DBMET00728 | |
| 0.021 | 0.054 | 0.042 | Retinoid X alpha receptor agonist | 0.042 0.018 DBMET00728 | DBMET00728 | |
| 0.028 | 0.063 | 0.059 | Adenosine deaminase inhibitor | 0.053 0.027 DBMET00728 0.059 0.022 DBMET00736 | DBMET00736 | |
| 0.031 | 0.068 | 0.057 | Carbonic anhydrase VB inhibitor | 0.057 0.038 DBMET00736 | DBMET00736 | |
| 0.018 | 0.055 | 0.027 | Sodium/glucose cotransporter inhibitor | 0.027 0.015 DBMET00736 | DBMET00736 | |
| 0.059 | 0.096 | 0.099 | Keratolytic | 0.099 0.031 DBMET00728 0.073 0.06 DBMET00736 | DBMET00728 | |
| 0.075 | 0.114 | 0.095 | Bile acid receptor antagonist | 0.095 0.06 DBMET00728 | DBMET00728 | |
| 0.024 | 0.063 | 0.046 | Glutamate (mGluR group II) antagonist | 0.046 0.018 DBMET00728 | DBMET00728 | |
| 0.041 | 0.08 | 0.088 | Phosphodiesterase III inhibitor | 0.088 0.029 DBMET00736 | DBMET00736 | |
| 0.047 | 0.087 | 0.057 | Leukotriene C antagonist | 0.057 0.036 DBMET00728 | DBMET00728 | |
| 0.018 | 0.06 | 0.027 | Glutamate (mGluR2) antagonist | 0.027 0.024 DBMET00728 | DBMET00728 | |
| 0.032 | 0.074 | 0.061 | Glutamate (mGluR4) antagonist | 0.061 0.013 DBMET00728 | DBMET00728 | |
| 0.043 | 0.085 | 0.058 | Sphingosine 1-phosphate receptor 1 antagonist | 0.058 0.033 DBMET00728 | DBMET00728 | |
| 0.019 | 0.061 | 0.035 | Phosphoglycerate kinase inhibitor | 0.035 0.024 DBMET00736 | DBMET00736 | |
| 0.016 | 0.06 | 0.04 | LFA antagonist | 0.04 0.008 DBMET00728 | DBMET00728 | |
| 0.028 | 0.072 | 0.056 | Mannosidase inhibitor | 0.044 0.034 DBMET00728 0.056 0.02 DBMET00736 | DBMET00736 | |
| 0.022 | 0.067 | 0.045 | Urate transporter 1 inhibitor | 0.045 0.022 DBMET00728 | DBMET00728 | |
| 0.02 | 0.064 | 0.034 | TRPM8 blocker | 0.034 0.032 DBMET00728 | DBMET00728 | |
| 0.013 | 0.057 | 0.021 | Lysophosphatidic acid 1 receptor antagonist | 0.021 0.016 DBMET00728 | DBMET00728 | |
| 0.023 | 0.068 | 0.042 | Retinoid X alpha receptor antagonist | 0.042 0.013 DBMET00728 | DBMET00728 | |
| 0.026 | 0.071 | 0.034 | Tryptophan 5 hydroxylase inhibitor | 0.034 0.03 DBMET00728 | DBMET00728 | |
| 0.032 | 0.078 | 0.054 | Glutamate (mGluR group III) antagonist | 0.054 0.017 DBMET00728 | DBMET00728 | |
| 0.045 | 0.091 | 0.061 | Carbonic anhydrase VA inhibitor | 0.061 0.059 DBMET00736 | DBMET00736 | |
| 0.029 | 0.077 | 0.042 | AICAR transformylase inhibitor | 0.042 0.034 DBMET00728 | DBMET00728 | |
| 0.07 | 0.117 | 0.109 | Carbonic anhydrase III inhibitor | 0.109 0.053 DBMET00728 0.098 0.064 DBMET00736 | DBMET00728 | |
| 0.025 | 0.073 | 0.048 | Retinoid X receptor antagonist | 0.048 0.014 DBMET00728 | DBMET00728 | |
| 0.013 | 0.061 | 0.046 | Arginase inhibitor | 0.046 0.018 DBMET00728 | DBMET00728 | |
| 0.015 | 0.064 | 0.495 | Protocollagen prolyl hydroxylase inhibitor | 0.495 0.002 DBMET00728 | DBMET00728 | |
| 0.038 | 0.088 | 0.066 | 3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor | 0.066 0.033 DBMET00728 | DBMET00728 | |
| 0.132 | 0.187 | 0.194 | Growth factor agonist | 0.194 0.069 DBMET00736 | DBMET00736 | |
| 0.014 | 0.069 | 0.058 | Retinoid X receptor agonist | 0.058 0.015 DBMET00728 | DBMET00728 | |
| 0.157 | 0.213 | 0.292 | Cholesterol antagonist | 0.292 0.096 DBMET00728 0.274 0.109 DBMET00736 | DBMET00728 | |
| 0.124 | 0.18 | 0.168 | Cyclin-dependent kinase 3 inhibitor | 0.168 0.063 DBMET00736 | DBMET00736 | |
| 0.034 | 0.091 | 0.074 | NMDA receptor glycine site agonist | 0.074 0.033 DBMET00728 | DBMET00728 | |
| 0.055 | 0.113 | 0.074 | MDM2 inhibitor | 0.074 0.029 DBMET00728 | DBMET00728 | |
| 0.041 | 0.101 | 0.12 | Catalase inhibitor | 0.12 0.033 DBMET00728 | DBMET00728 | |
| 0.073 | 0.133 | 0.107 | Mucolytic | 0.107 0.068 DBMET00728 0.106 0.07 DBMET00736 | DBMET00728 | |
| 0.05 | 0.111 | 0.099 | Ornithine decarboxylase inhibitor | 0.099 0.046 DBMET00728 | DBMET00728 | |
| 0.038 | 0.1 | 0.06 | Glucosylceramidase inhibitor | 0.06 0.031 DBMET00736 | DBMET00736 | |
| 0.024 | 0.089 | 0.042 | AMPA 4 receptor antagonist | 0.042 0.024 DBMET00728 | DBMET00728 | |
| 0.032 | 0.099 | 0.055 | Leukotriene B4 antagonist | 0.055 0.034 DBMET00728 | DBMET00728 | |
| 0.08 | 0.148 | 0.114 | Toll-Like receptor 2 antagonist | 0.114 0.084 DBMET00736 | DBMET00736 | |
| 0.025 | 0.093 | 0.046 | Dihydroorotase inhibitor | 0.046 0.029 DBMET00728 | DBMET00728 | |
| 0.061 | 0.13 | 0.087 | Ephrin antagonist | 0.087 0.076 DBMET00736 | DBMET00736 | |
| 0.021 | 0.093 | 0.042 | GABA uptake inhibitor | 0.042 0.023 DBMET00728 | DBMET00728 | |
| 0.017 | 0.09 | 0.035 | Carnitine palmitoyltransferase 1 inhibitor | 0.035 0.022 DBMET00728 | DBMET00728 | |
| 0.07 | 0.143 | 0.109 | Alkylator | 0.109 0.079 DBMET00736 | DBMET00736 | |
| 0.044 | 0.119 | 0.059 | Interferon inducer | 0.059 0.056 DBMET00736 | DBMET00736 | |
| 0.05 | 0.126 | 0.105 | Monophenol monooxygenase inhibitor | 0.105 0.072 DBMET00728 0.094 0.081 DBMET00736 | DBMET00728 | |
| 0.056 | 0.133 | 0.103 | HIV-1 integrase (Overall Integration) inhibitor | 0.096 0.058 DBMET00728 0.103 0.052 DBMET00736 | DBMET00736 | |
| 0.056 | 0.133 | 0.103 | Mediator release inhibitor | 0.103 0.066 DBMET00728 | DBMET00728 | |
| 0.051 | 0.128 | 0.075 | Carbonic anhydrase VI inhibitor | 0.074 0.066 DBMET00728 0.075 0.063 DBMET00736 | DBMET00736 | |
| 0.015 | 0.095 | 0.034 | Carnitine palmitoyltransferase inhibitor | 0.034 0.023 DBMET00728 | DBMET00728 | |
| 0.033 | 0.113 | 0.05 | Sphingosine kinase 2 inhibitor | 0.05 0.047 DBMET00736 | DBMET00736 | |
| 0.055 | 0.14 | 0.072 | Sphingosine 1-phosphate receptor antagonist | 0.072 0.064 DBMET00728 | DBMET00728 | |
| 0.032 | 0.124 | 0.063 | Leukotriene antagonist | 0.063 0.047 DBMET00728 | DBMET00728 | |
| 0.004 | 0.099 | 0.019 | Kainate receptor 1 antagonist | 0.019 0.016 DBMET00728 | DBMET00728 | |
| 0.055 | 0.152 | 0.652 | Uric acid excretion stimulant | 0.652 0.003 DBMET00728 0.115 0.041 DBMET00736 | DBMET00728 | |
| 0.012 | 0.112 | 0.047 | Kainate receptor antagonist | 0.047 0.023 DBMET00728 | DBMET00728 | |
| 0.01 | 0.11 | 0.033 | Kainate receptor 2 antagonist | 0.033 0.028 DBMET00728 | DBMET00728 | |
| 0.042 | 0.145 | 0.094 | Potassium channel (Ca-activated) activator | 0.094 0.061 DBMET00728 | DBMET00728 | |
| 0.031 | 0.138 | 0.05 | Thromboxane synthase inhibitor | 0.05 0.049 DBMET00728 | DBMET00728 | |
| 0.018 | 0.159 | 0.32 | Bruton tyrosine kinase inhibitor | 0.32 0.004 DBMET00736 | DBMET00736 | |
| 0.05 | 0.197 | 0.122 | Glutamate receptor antagonist | 0.122 0.072 DBMET00728 | DBMET00728 | |
| 0.074 | 0.222 | 0.141 | Phospholipase A2 inhibitor | 0.141 0.084 DBMET00728 | DBMET00728 | |
| 0.026 | 0.179 | 0.051 | Factor IXa inhibitor | 0.051 0.036 DBMET00728 | DBMET00728 | |
| 0.084 | 0.239 | 0.196 | Interleukin agonist | 0.162 0.156 DBMET00728 0.196 0.125 DBMET00736 | DBMET00736 | |
| 0.017 | 0.173 | 0.049 | Thromboxane antagonist | 0.049 0.043 DBMET00728 | DBMET00728 | |
| 0.117 | 0.282 | 0.205 | Hypoxia-inducible factor 1 alpha inhibitor | 0.205 0.146 DBMET00728 | DBMET00728 | |
| 0.126 | 0.293 | 0.218 | Antithrombotic | 0.218 0.157 DBMET00728 0.2 0.178 DBMET00736 | DBMET00728 | |
| 0.015 | 0.183 | 0.058 | Purinergic P2Y2 antagonist | 0.058 0.008 DBMET00728 | DBMET00728 | |
| 0.008 | 0.186 | 0.024 | Retinoic acid receptor agonist | 0.024 0.015 DBMET00728 | DBMET00728 | |
| 0.098 | 0.304 | 0.133 | CC chemokine 6 receptor antagonist | 0.133 0.06 DBMET00728 | DBMET00728 | |
| 0.016 | 0.232 | 0.044 | Nicotinic acid receptor 1 agonist | 0.044 0.025 DBMET00728 | DBMET00728 | |
| 0.005 | 0.249 | 0.025 | Leukotriene B4 receptor 1 antagonist | 0.025 0.022 DBMET00728 | DBMET00728 | |
| 0.009 | 0.26 | 0.04 | Factor XIa inhibitor | 0.04 0.029 DBMET00728 | DBMET00728 | |
| 0.025 | 0.282 | 0.074 | Adrenaline agonist | 0.074 0.066 DBMET00736 | DBMET00736 | |
| 0.029 | 0.303 | 0.13 | Vascular endothelial growth factor 3 antagonist | 0.13 0.085 DBMET00736 | DBMET00736 | |
| 0.019 | 0.342 | 0.131 | Prostaglandin F2 alpha antagonist | 0.131 0.005 DBMET00728 | DBMET00728 | |
| 0.078 | 0.441 | 0.353 | Nootropic | 0.353 0.053 DBMET00736 | DBMET00736 | |
| 0.022 | 0.389 | 0.172 | Bronchodilator | 0.172 0.024 DBMET00736 | DBMET00736 | |
| 0.004 | 0.39 | 0.113 | Retinoid X gamma receptor agonist | 0.113 0.003 DBMET00728 | DBMET00728 | |
| 0.032 | 0.439 | 0.066 | Prolactin release inhibitor | 0.066 0.03 DBMET00736 | DBMET00736 | |
| 0.003 | 0.427 | 0.024 | Retinoid X beta receptor agonist | 0.024 0.012 DBMET00728 | DBMET00728 | |
| 0.11 | 0.56 | 0.364 | Calcium channel L-type activator | 0.364 0.107 DBMET00736 | DBMET00736 | |
| 0.002 | 0.485 | 0.013 | Retinoic acid beta receptor antagonist | 0.013 0.007 DBMET00728 | DBMET00728 | |
| 0.056 | 0.555 | 0.175 | Lipocortins synthesis antagonist | 0.175 0.076 DBMET00728 | DBMET00728 | |
| 0.002 | 0.51 | 0.012 | Retinoic acid receptor gamma antagonist | 0.012 0.008 DBMET00728 | DBMET00728 | |
| 0.019 | 0.531 | 0.124 | Thrombolytic | 0.124 0.105 DBMET00728 | DBMET00728 | |
| 0.003 | 0.568 | 0.021 | Retinoic acid receptor antagonist | 0.021 0.01 DBMET00728 | DBMET00728 | |
| 0.004 | 0.573 | 0.027 | Retinoid X gamma receptor antagonist | 0.027 0.019 DBMET00728 | DBMET00728 | |
| 0.005 | 0.591 | 0.024 | Retinoic acid gamma receptor agonist | 0.024 0.012 DBMET00728 | DBMET00728 | |
| 0.004 | 0.595 | 0.069 | Prostaglandin E2 antagonist | 0.069 0.024 DBMET00728 | DBMET00728 | |
| 0.003 | 0.604 | 0.042 | Prostaglandin EP1 antagonist | 0.042 0.008 DBMET00728 | DBMET00728 | |
| 0.019 | 0.626 | 0.075 | Adenine nucleotide translocase inhibitor | 0.075 0.012 DBMET00728 | DBMET00728 | |
| 0.014 | 0.628 | 0.076 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.076 0.072 DBMET00728 | DBMET00728 | |
| 0 | 0.623 | 0.009 | Mannitol 2-dehydrogenase inhibitor | 0.009 0.005 DBMET00728 | DBMET00728 | |
| 0.004 | 0.701 | 0.022 | Retinoic acid beta receptor agonist | 0.022 0.011 DBMET00728 | DBMET00728 | |
| 0.005 | 0.709 | 0.029 | Purinergic P2Y14 antagonist | 0.029 0.023 DBMET00728 | DBMET00728 | |
| 0.005 | 0.722 | 0.045 | Plasminogen activator inhibitor antagonist | 0.045 0.039 DBMET00728 | DBMET00728 | |
| 0.005 | 0.725 | 0.052 | Retinoic acid alpha receptor agonist | 0.052 0.013 DBMET00728 | DBMET00728 | |
| 0.002 | 0.735 | 0.021 | Retinoic acid alpha receptor antagonist | 0.021 0.014 DBMET00728 | DBMET00728 | |
| 0.022 | 0.794 | 0.086 | Transcription factor NF kappa B stimulant | 0.086 0.058 DBMET00736 | DBMET00736 | |
| 0.003 | 0.779 | 0.024 | Adenosine A1 receptor agonist | 0.024 0.017 DBMET00736 | DBMET00736 | |
| 0.009 | 0.789 | 0.04 | Glutamate (mGluR8) antagonist | 0.04 0.017 DBMET00728 | DBMET00728 | |
| 0.005 | 0.816 | 0.053 | Neuraminidase (Influenza A) inhibitor | 0.053 0.019 DBMET00728 | DBMET00728 | |
| 0.004 | 0.841 | 0.07 | Neuraminidase (influenza) inhibitor | 0.07 0.035 DBMET00728 | DBMET00728 | |
| 0.042 | 0.887 | 0.329 | Interleukin 2 agonist | 0.329 0.056 DBMET00736 | DBMET00736 | |
| 0.003 | 0.884 | 0.066 | Neuraminidase inhibitor | 0.066 0.037 DBMET00728 | DBMET00728 | |
| 0.016 | 0.919 | 0.157 | ABCA1 expression enhancer | 0.157 0.016 DBMET00728 | DBMET00728 | |
| 0.002 | 0.967 | 0.03 | NMDA 2D receptor antagonist | 0.03 0.015 DBMET00728 | DBMET00728 | |
| 0.005 | 0.982 | 0.048 | Factor III inhibitor | 0.048 0.04 DBMET00728 | DBMET00728 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |